| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. | Director | Common Stock | 3,430 | $5,179 | $1.51 | 10 Jan 2026 | Direct |
| Eledon Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | 10 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals, Inc. | 10 Jan 2026 | 2 | $0 | 4 | Director | 16 Jan 2026, 17:00 |
| ELDN | Eledon Pharmaceuticals, Inc. | 10 Jan 2025 | 2 | $0 | 4 | Director | 13 Jan 2025, 17:30 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 May 2023 | 1 | $0 | 4 | Director | 02 May 2023, 18:42 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2023 | 1 | $0 | 4 | Director | 02 Feb 2023, 16:58 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Director | 02 Feb 2022, 16:29 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Jul 2021 | 0 | $0 | 3 | Director | 09 Jul 2021, 20:09 |